Searcharxiv⌕ Search

arXiv subjects

Carmen Jimenez-Mesa

Publications and source records attributed to Carmen Jimenez-Mesa.

2 recordsLinked to original sources

A continually expandable foundation model for brain MRI

Brain magnetic resonance imaging (MRI) is central to neuroscience and clinical assessment, but models are commonly developed for individual diseases, populations or imaging protocols. Foundation models promise more general representations, yet they are usually pretrained once and can lose earlier capabilities when updated with new data. Here we show that Alcmaeon, a three-dimensional brain MRI foundation model pretrained without manual labels on more than 425,000 volumes and derived imaging maps, can be expanded sequentially across clinical domains. Alcmaeon combines volumetric encoding and latent diffusion generation with Graph-Blueprint Pruning (GBP), which protects network modules important to earlier domains while leaving the remaining capacity trainable. Across expansion from healthy ageing and neurodegeneration to developmental, psychiatric and tumour imaging, GBP showed less forgetting than sequential adaptation and elastic weight consolidation across voxel-level reconstruction measures, with its largest advantage after adaptation to tumour imaging. The blueprints provided an inspectable record of how model capacity was protected and reused. Representations from different model levels supported image synthesis, disease classification, survival modelling and postoperative prediction, although no single representation was optimal for every task. These findings provide a route towards brain MRI foundation models that can grow with emerging data while retaining earlier capabilities.

cs.CV↗

Uncovering Neuroimaging Biomarkers of Brain Tumor Surgery with AI-Driven Methods

Brain tumor resection is a highly complex procedure with profound implications for survival and quality of life. Predicting patient outcomes is crucial to guide clinicians in balancing oncological control with preservation of neurological function. However, building reliable prediction models is severely limited by the rarity of curated datasets that include both pre- and post-surgery imaging, given the clinical, logistical and ethical challenges of collecting such data. In this study, we develop a novel framework that integrates explainable artificial intelligence (XAI) with neuroimaging-based feature engineering for survival assessment in brain tumor patients. We curated structural MRI data from 49 patients scanned pre- and post-surgery, providing a rare resource for identifying survival-related biomarkers. A key methodological contribution is the development of a global explanation optimizer, which refines survival-related feature attribution in deep learning models, thereby improving both the interpretability and reliability of predictions. From a clinical perspective, our findings provide important evidence that survival after oncological surgery is influenced by alterations in regions related to cognitive and sensory functions. These results highlight the importance of preserving areas involved in decision-making and emotional regulation to improve long-term outcomes. From a technical perspective, the proposed optimizer advances beyond state-of-the-art XAI methods by enhancing both the fidelity and comprehensibility of model explanations, thus reinforcing trust in the recognition patterns driving survival prediction. This work demonstrates the utility of XAI-driven neuroimaging analysis in identifying survival-related variability and underscores its potential to inform precision medicine strategies in brain tumor treatment.

eess.IV↗